Results 231 to 240 of about 14,066,519 (402)
When the Money Stops: A Safety-First Plan for Paused Clinical Trials. [PDF]
Smith D.
europepmc +1 more source
Conventional quality-of-life data analyses underestimate gains in Mantle Cell Lymphoma clinical trials: A re-examination of enrich study data [PDF]
Jeremy Hobart +19 more
openalex +1 more source
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
The status quo of the development of decentralized clinical trials. [PDF]
Chen X +7 more
europepmc +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
An assessment of the informativeness of clinical trials in digital mental health. [PDF]
O'Dea B +6 more
europepmc +1 more source

